Kaarst, Germany

Nicole Seip

This inventor holds 1 USPTO granted patent. Top assignee: Bioecho Life Sciences Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicole Seip. Retrieved from https://idiyas.com/inventor/nicole-seip-50d17p3n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicole Seip and Nucleic Acid Isolation Innovation.

Introduction

Nicole Seip is an inventor based in Kaarst, Germany. Her patent work concerns methods for isolating nucleic acids from samples, including approaches designed for use at elevated temperatures.

Latest Patents

Seip is associated with 1 patent: “Isolation of nucleic acids at elevated temperatures.” The invention describes using a solution containing a reducing agent, preferably one of formula (I), an anionic detergent, and a buffering substance to isolate nucleic acids from a sample. It also covers the corresponding solutions and a kit comprising them.

Career Highlights

Seip’s listed patent is connected with Bioecho Life Sciences GmbH, a company working in the life sciences field. The invention highlights her contribution to nucleic acid isolation methods and related laboratory solutions.

Collaborations

The supplied information names Joerg Hucklenbroich and Maximilian Weiter as Seip’s coworkers. Their shared company affiliation provides context for her professional environment, though specific roles in the patent are not provided.

Conclusion

Nicole Seip’s patent focuses on a solution-based approach to isolating nucleic acids at elevated temperatures, alongside related solutions and a kit.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…